glp-1 constipation legal team in michigan Food Companies Are Targeting Users of Weight-Loss Drugs With 'GLP-1 Friendly' Labels My Journey with GLP-1: Week

UTIs are common in the general population, especially among women, and coincidental timing with tirzepatide use can create a false association

These effects are typically dose-dependent and often improve with continued treatment as the body adapts to the medication, particularly if the dose is increased gradually as recommended

We're also seeing a migration toward direct-to-consumer platforms like LillyDirect and NovoCare, where patients can access these medications at more predictable prices, Long said

Patients should never start, stop, or combine these medications without explicit guidance from their healthcare provider

Two, many plans do not consider weight loss drugs necessary, and three, some insurance companies may be concerned about inappropriate prescribing, she says